LI-RADS
Cross-source consensus on LI-RADS from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Other
Highlighted claims
- CT classification in the study follows LI-RADS CT/MRI v2018 and LI-RADS CT/MRI Nonradiation TRA v2024 Core. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
- LR-5 or LR-TR viable findings confirm recurrent HCC in the reference standard pathway. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
- LI-RADS categories are mapped to positive, subthreshold, and negative categories for trial interpretation. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
- The reference standard complete dynamic MRI is interpreted with LI-RADS. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
- LR-4, LR-M, or LR-TIV findings prompt multidisciplinary discussion and possible additional imaging or biopsy. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol